T 0171/15 (Anti-connexin peptides/OCUNEXUS THERAPEUTICS) of 12.03.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T017115.20190312
- Date of decision
- 12 March 2019
- Case number
- T 0171/15
- Petition for review of
- -
- Application number
- 08868841.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions
- Applicant name
- Ocunexus Therapeutics, Inc.
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 113(1)European Patent Convention Art 113(2)European Patent Convention R 103(1)(a)European Patent Convention R 111(2)Rules of procedure of the Boards of Appeal Art 11
- Keywords
- Substantial procedural violation - appealed decision reasoned (no)
Substantial procedural violation - violation of the right to be heard (yes)
Basis of decision - text submitted or agreed by applicant (no)
Remittal to the department of first instance - (yes)
Reimbursement of appeal fee - equitable by reason of a substantial procedural violation - Catchword
- -
- Cited cases
- T 0952/07
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division for further prosecution.
3. The appeal fee is to be reimbursed in full.